The head of the French anti-doping agency (AFLD) Pierre Bordry has confirmed that Riccardo Ricco, Moises Duenas and Manuel Beltran all tested positive for CERA, the third generation form of EPO.
CERA or Continuous Erythropoiesis Receptor Activator is a new form of EPO, created by the Swiss company Roche, that has been created to help dialysis patients or people with kidney problems.
The drug stimulates the kidneys to produce EPO which in turn stimulates the bone marrow to increase the creation of red blood cells. More red blood cells allow the body to carry more oxygen and so increases an athlete's performance.
CERA, or Mircera as it is known commercially, has been approved for medical use in Switzerland and Australia and is close to final approval across Europe. Roche applied to sell the drug in the USA last year but the Food and Drug Administration (FDA) refused to approve the drug for use in the USA because it infringed patents belonging to the original creator and producer of EPO, the US-based Amgen, that sponsors the Tour of California.
CERA offers benefits over older forms of EPO because it is has a slower release rate or creation of red blood cells in the body. For patients that means fewer injections, perhaps even just once a month, and lower health care costs for hospitals. For athletes it means they can take the blood booster less frequently and so reduce the risk of being caught because EPO is difficult to detect a few days after it has been injected.
A test for EPO was first introduced for the 2000 Sydney Olympics. CERA is on the WADA list of banned products but it seems that riders thought that the test was unable to find CERA. WADA is known to be working on a test but it seems the testers have caught up with the dopers far quicker than anyone expected.
Three riders have been so far in this year?s Tour de France and now the worry is that other riders could have taken CERA. The AFLD have confirmed that other riders have been tested several times in the first half of the Tour de France and so in theory, other riders could result positive for CERA in the next few days.
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
Swipe to scroll horizontally
TOUR DE FRANCE 2008: STAGE REPORTS
Stage 11: Arvesen wins
Stage 10: Evans takes yellow jersey by one second
Stage nine: Ricco wins in the Pyrenees
Stage eight: Cavendish wins again in Toulouse
Stage seven: Sanchez takes action-packed stage
Stage six: Ricco storms to win
Stage five: Cavendish takes first Tour win
Stage four: Schumacher wins TT and takes race lead
Stage three: Dumoulin wins stage from break
Stage two: Hushovd wins chaotic sprint
Stage one: Valverde wins
Swipe to scroll horizontally
TOUR DE FRANCE 2008: NEWS
Analysis: Tour de France rest day summary
Cavendish battles through Pyrenees
Evans suffers but takes yellow jersey [stage 10]
Analysis: Hautacam shakes up 2008 Tour
Ricco silences critics with solo attack in Pyrenees [stage nine]
Cavendish talks about his second stage win [stage eight]
Beltran heads home but doubts remain about other Tour riders
David Millar: the dope controls are working
Manuel Beltran tests positive for EPO at the Tour
Comment: How the Tour rediscovered its spirit
Doping back in Tour de France headlines
Millar: close but no cigar in Super-Besse [stage six]
Super-Besse shows form of main contenders [stage six]
Millar to go for yellow [stage six]
Team Columbia's reaction to Cavendish's win [stage five]
Cavendish talks about his Tour stage win
Tour comment: Why Evans should be happy [stage four]
Millar: Still aiming for Tour yellow jersey [stage 4]
Who is Romain Feillu?
Cavendish disappointed with stage two result
Millar too close to Tour yellow jersey
Stage 2 preview: A sprint finish for Cavendish?
Millar happy after gains precious seconds in Plumelec
Valverde delighted with opening Tour stage win
Comment: Is Valverde's win a good thing for the Tour?
Founded in 1891, Cycling Weekly and its team of expert journalists brings cyclists in-depth reviews, extensive coverage of both professional and domestic racing, as well as fitness advice and 'brew a cuppa and put your feet up' features. Cycling Weekly serves its audience across a range of platforms, from good old-fashioned print to online journalism, and video.
Rapha's loss, your gain: prices slashed sitewide amid profitability concerns
A phone app saved my life after a crash, you shouldn't ride anywhere remote without it
